Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(14%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_3
1
14%
Ph not_applicable
2
29%
Ph phase_2
2
29%
Ph phase_4
1
14%

Phase Distribution

0

Early Stage

2

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 2Efficacy & side effects
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(4)
Terminated(1)
Other(1)

Detailed Status

Completed4
Recruiting1
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (33.3%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

completed457%
recruiting114%
unknown114%
withdrawn114%

Recent Activity

1 active trials
Showing 5 of 7
recruitingphase_2

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

NCT05020912
completednot_applicable

Acute Effects of Fats on Satiety and Energy Needs

NCT02496936
completed

Fluorescence and Glioma Heterogeneity

NCT02155452
completednot_applicable

Fatty Acid Desaturase Gene Locus Interactions With Diet (FADSDIET2)

NCT03572205
unknownphase_4

Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention

NCT03642535
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05020912Phase 2

Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic Therapy

Recruiting
NCT02496936Not Applicable

Acute Effects of Fats on Satiety and Energy Needs

Completed
NCT02155452

Fluorescence and Glioma Heterogeneity

Completed
NCT03572205Not Applicable

Fatty Acid Desaturase Gene Locus Interactions With Diet (FADSDIET2)

Completed
NCT03642535Phase 4

Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and Prevention

Unknown
NCT02632110Phase 2

Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face

Completed
NCT03024060Phase 3

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Withdrawn

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7